Latest News

MIRA Pharmaceuticals Advances Ketamir-2 to Phase 2a in Chemotherapy-Induced Peripheral Neuropathy (CIPN) Following FDA Review

Cemtrex's Vicon Secures Approximately $2.8 Million in Orders from U.S. Federal Government Agency

Stifel Expands Venture Banking Presence Across East Coast With Senior Hires

Capricor Therapeutics to Present HOPE-3 and HOPE-3 Open-Label Extension Data at 2026 World Muscle Society Congress

Forge Nano Expands Partnership with Battery AI Software Leader Voltaiq to Put AI at the Center of Battery Development and Manufacturing

TOMI’s SteraMist Integrated System (SIS) Strategy Converts to Orders: Enclosure Sales Reach $2.3 Million YTD

Pasqal to Ring Nasdaq Closing Bell on September 17th

Duke Robotics Appoints Capital Markets and Public Company Finance Veteran Avi Levin as Chief Financial Officer

Pure Cycle Corporation to Participate in the Lytham Partners Fall 2026 Investor Conference

PetMeds Appoints Jeff Willard as CEO & President and Announces Board Leadership Transition